Deferasirox Granule
Product Images NDC 59651-449

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 59651-449). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Deferasirox Fig1)

A bar chart showing changes in liver iron concentration and serum ferritin following oral administration of Deferasirox tablets at doses from 5 to 30 mg/kg/day. The x-axis represents Deferasirox dose in mg/kg/day, while the y-axes show change in liver iron content (mg Fe/g dw) on the left and change in serum ferritin (mcg/L) on the right. White bars indicate liver iron content, and black bars indicate serum ferritin, with data points presented across different dose groups.*

FDA Label Image

Deferasirox-fig2.jpg (Deferasirox Fig2)

Packaging label for Deferasirox Oral Granules 90 mg sachet by Aurobindo Pharma Limited. The label includes instructions for pharmacists, NDC number 59651-447-38, and states each sachet contains 138.5 mg granules equivalent to 90 mg deferasirox. It also provides handling and administration instructions.*

FDA Label Image

Deferasirox-fig3.jpg (Deferasirox Fig3)

Box label for Deferasirox Oral Granules 90 mg by Aurobindo Pharma Limited. The label states the product contains 30 sachets, each with 138.5 mg granules equivalent to 90 mg deferasirox. It includes patient instructions for use, dosing storage conditions, and distributor address.*

FDA Label Image

Deferasirox-fig4.jpg (Deferasirox Fig4)

Deferasirox Oral Granules 180 mg sachet label from Aurobindo Pharma Limited. The label includes NDC 59651-448-77 and states each sachet contains 277 mg granules equivalent to 180 mg deferasirox. Instructions for pharmacists to dispense the Medication Guide are present, along with basic patient instructions. The Aurobindo logo appears at the bottom.*

FDA Label Image

Deferasirox-fig5.jpg (Deferasirox Fig5)

Deferasirox Oral Granules 180 mg carton label for oral use by Aurobindo Pharma Limited. The label states each sachet contains 277 mg granules equivalent to 180 mg Deferasirox. It is an Rx only medication, with 30 sachets per package. Storage and dosage instructions are referenced, and the product is distributed by Aurobindo Pharma USA, Inc.*

FDA Label Image

Deferasirox-fig6.jpg (Deferasirox Fig6)

Packaging label for Deferasirox Oral Granules 360 mg from Aurobindo Pharma Limited. The label indicates that each sachet contains 554 mg of granules equivalent to 360 mg deferasirox. It includes the NDC 59651-449-54 and states Rx only with instructions for the pharmacist to dispense the Medication Guide separately to patients.*

FDA Label Image

Deferasirox-fig7.jpg (Deferasirox Fig7)

Packaging label for Deferasirox Oral Granules 360 mg by Aurobindo Pharma Limited. The label states the product is prescription-only and includes instructions for pharmacists to dispense a Medication Guide. Each sachet contains 554 mg granules equivalent to 360 mg deferasirox, with 30 sachets per package. Storage instructions and distributor information for Aurobindo Pharma USA, Inc. are also present.*

FDA Label Image

Str (Deferasirox Str)

Chemical structure diagram of Deferasirox, showing the arrangement of its molecular components including hydroxyl and aromatic rings connected by nitrogen atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.